X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47035) 47035
Newspaper Article (1283) 1283
Newsletter (795) 795
Book Chapter (304) 304
Magazine Article (54) 54
Book / eBook (35) 35
Dissertation (24) 24
Transcript (20) 20
Publication (9) 9
Trade Publication Article (8) 8
Conference Proceeding (7) 7
Web Resource (6) 6
Reference (4) 4
Book Review (3) 3
Government Document (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35609) 35609
transplantation (20432) 20432
stem cells (20426) 20426
male (18608) 18608
female (18073) 18073
hematology (15909) 15909
adult (13799) 13799
middle aged (12891) 12891
oncology (11776) 11776
animals (10294) 10294
hematopoietic stem cell transplantation - adverse effects (9566) 9566
immunology (8271) 8271
hematopoietic stem cells (8201) 8201
adolescent (7434) 7434
treatment outcome (7429) 7429
stem cell transplantation (6988) 6988
aged (6985) 6985
bone-marrow-transplantation (6394) 6394
stem-cell transplantation (6294) 6294
care and treatment (6105) 6105
hematopoietic stem cell transplantation (6080) 6080
research (5793) 5793
cancer (5748) 5748
health aspects (5732) 5732
bone marrow (5578) 5578
child (5452) 5452
transplantation, homologous (5365) 5365
chemotherapy (5291) 5291
therapy (5006) 5006
risk factors (4952) 4952
retrospective studies (4492) 4492
young adult (4488) 4488
analysis (4330) 4330
mice (4167) 4167
leukemia (4088) 4088
transplants & implants (4049) 4049
cell biology (3890) 3890
medicine, research & experimental (3797) 3797
child, preschool (3660) 3660
hematopoietic stem cell transplantation - methods (3641) 3641
versus-host-disease (3494) 3494
transplantation, autologous (3365) 3365
disease (3112) 3112
prognosis (3074) 3074
stem-cells (2977) 2977
patients (2931) 2931
medicine & public health (2867) 2867
clinical trials (2836) 2836
bone-marrow (2803) 2803
antineoplastic combined chemotherapy protocols - therapeutic use (2799) 2799
medicine (2744) 2744
survival (2719) 2719
cell & tissue engineering (2703) 2703
children (2671) 2671
graft vs host disease - etiology (2669) 2669
hematology, oncology and palliative medicine (2666) 2666
regeneration (2595) 2595
mortality (2554) 2554
medical research (2476) 2476
progenitor cells (2466) 2466
infant (2448) 2448
pediatrics (2417) 2417
diagnosis (2389) 2389
review (2360) 2360
blood (2319) 2319
time factors (2308) 2308
follow-up studies (2299) 2299
differentiation (2288) 2288
surgery (2268) 2268
biotechnology & applied microbiology (2239) 2239
transplantation conditioning - methods (2233) 2233
mesenchymal stem-cells (2224) 2224
survival analysis (2224) 2224
combined modality therapy (2217) 2217
in-vitro (2210) 2210
expression (2171) 2171
recurrence (2140) 2140
usage (2130) 2130
bone marrow transplantation (2103) 2103
gene expression (2068) 2068
disease-free survival (2037) 2037
stem cell transplantation - adverse effects (2034) 2034
cells, cultured (2033) 2033
stromal cells (2002) 2002
multiple myeloma (1968) 1968
apoptosis (1951) 1951
cell differentiation (1947) 1947
tissue engineering (1945) 1945
complications and side effects (1908) 1908
antineoplastic combined chemotherapy protocols - adverse effects (1886) 1886
acute myeloid-leukemia (1878) 1878
patient outcomes (1842) 1842
survival rate (1836) 1836
recipients (1814) 1814
studies (1811) 1811
immunotherapy (1807) 1807
rats (1774) 1774
disease models, animal (1771) 1771
prospective studies (1770) 1770
mesenchyme (1768) 1768
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (48719) 48719
Chinese (420) 420
Japanese (313) 313
German (216) 216
French (148) 148
Spanish (128) 128
Portuguese (62) 62
Russian (61) 61
Polish (42) 42
Czech (32) 32
Italian (31) 31
Dutch (14) 14
Norwegian (14) 14
Hungarian (12) 12
Korean (11) 11
Swedish (10) 10
Finnish (9) 9
Croatian (7) 7
Danish (5) 5
Turkish (5) 5
Slovak (4) 4
Serbian (2) 2
Bosnian (1) 1
Hebrew (1) 1
Persian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 10, pp. 895 - 905
.... However, since autologous stem-cell transplantation has substantial toxic effects and requires prolonged hospitalization, the comparison with less toxic, orally administered treatments is important... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 25, pp. 2433 - 2444
Journal Article
Bone marrow transplantation (Basingstoke), ISSN 1476-5365, 2010, Volume 46, Issue 1, pp. 98 - 104
.... A majority of patients with DC develop BM failure (BMF). Hematopoietic cell transplantation (HCT... 
hematopoietic cell transplantation | dyskeratosis congenita | reduced-intensity conditioning regimen | ALEMTUZUMAB | CYCLOPHOSPHAMIDE | BONE-MARROW-TRANSPLANTATION | ANTITHYMOCYTE GLOBULIN | IMMUNOLOGY | FANCONI-ANEMIA | FLUDARABINE | TRANSPLANTATION | CORD BLOOD TRANSPLANTATION | ONCOLOGY | PATIENT | HEMATOLOGY | APLASTIC-ANEMIA | MELPHALAN | Antibodies, Neoplasm - therapeutic use | Cyclophosphamide - administration & dosage | Peripheral Blood Stem Cell Transplantation - adverse effects | Humans | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Whole-Body Irradiation - adverse effects | Young Adult | Antibodies, Monoclonal, Humanized | Cord Blood Stem Cell Transplantation - adverse effects | Antineoplastic Agents - adverse effects | Dyskeratosis Congenita - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Pulmonary Fibrosis - etiology | Vidarabine - adverse effects | Vidarabine - analogs & derivatives | Alemtuzumab | Antibodies, Neoplasm - administration & dosage | Vidarabine - therapeutic use | Combined Modality Therapy - adverse effects | Dyskeratosis Congenita - physiopathology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Pulmonary Fibrosis - prevention & control | Bone Marrow Transplantation - adverse effects | Vidarabine - administration & dosage | Antibodies, Neoplasm - adverse effects | Epithelial cells | Patient outcomes | Abnormalities | Physiological aspects | Development and progression | Transplantation | Hematopoietic stem cells | Risk factors
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 874 - 885
Summary Background Relapsed multiple myeloma has no standard treatment, and the role of autologous stem-cell transplantation (ASCT... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE | SUPERIORITY | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | IMPACT | ONCOLOGY | CLINICAL-TRIALS | LENALIDOMIDE | SALVAGE THERAPY | MARROW-TRANSPLANTATION | INDUCTION | COMBINATION | Recurrence | Cyclophosphamide - administration & dosage | Peripheral Nervous System Diseases - chemically induced | Consolidation Chemotherapy - methods | Humans | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Multiple Myeloma - therapy | Time Factors | Adult | Female | Boronic Acids - administration & dosage | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Proportional Hazards Models | Thrombocytopenia - chemically induced | Disease Progression | Induction Chemotherapy - adverse effects | Retreatment | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged | Multiple Myeloma - genetics | Stem Cell Transplantation - adverse effects | Care and treatment | Relapse | Multiple myeloma | Clinical trials | Transplantation | Diseases | Cyclophosphamide | Chemotherapy | Hospitals | Stem cells | Dosage and administration | Product development | Cancer
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 14, pp. 1311 - 1320
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
...–cytarabine combination therapy (the MATRix regimen), followed by a second randomisation comparing consolidation with whole-brain radiotherapy or autologous stem cell transplantation in patients with primary CNS lymphoma... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 14, pp. 1598 - 1605
Journal Article
Blood, ISSN 1528-0020, 2016, Volume 127, Issue 11, pp. 1502 - 1508
Journal Article